• Ticker

DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

Luminex Corp

NASDAQ:LMNX

$22.78 -$0.33 (-1.43%)

REAL-TIME: Last trade at

In-Vitro Diagnostics (IVD) Market (Clinical Chemistry, Immunoassays, Molecular Diagnostics, Hematology Analyzers & Microbiology Culture) - Global Trends & Forecasts to 2016

Luminex backs 2012 revenue $205M-$215M, consensus $210.06M

Luminex reports Q1 EPS 8c, consensus 8c

Luminex Corp (LMNX) Tops Q1 EPS by 1c

Luminex Corporation Reports First Quarter 2012 Results

Luminex Corporation Reports First Quarter 2012 Results

Luminex Corporation Receives CE Mark For Revolutionary Newborn Screening Platform

Luminex Corporation Receives CE Mark for Revolutionary Newborn Screening Platform

Luminex Corporation Expands Life Science and Biodefense Groups

Luminex announces expansion of Life Science and Biodefense Groups

Luminex Corporation Expands Life Science and Biodefense Groups

Luminex Corporation First Quarter Earnings Release Scheduled for April 30, 2012

Luminex Corp. (LMNX) Jumped To A New High After Luminex Announcement

Luminex, Bio-Rad extend global sales and distribution agreement to 2023

Luminex and Bio-Rad Extend Their Global Sales and Distribution Agreement to 2023

Luminex Corporation to Speak at Joint Department of Defense and Environmental Protection Agency 5th National Bio-Threat Conference

Luminex incentive plan a positive signal to market, says William Blair

Stephens to host a teleconference

Leerink views NIH budget proposal as positive for Life Science names

Luminex Corporation to Present at Upcoming Investment Conferences in February and March

Luminex Corporation to Present at Upcoming Investment Conferences in February and March

Luminex Corporation Reports Fourth Quarter and Full Year 2011 Results

Luminex sees FY12 revenue $205M-$215M vs. consensus $211.14M

Luminex reports Q4 EPS 11c vs. consensus 7c

Luminex Corp (LMNX) Tops Q4 EPS by 4c; Guides FY12 Revs Above

Luminex downgraded to Underperform from Neutral at Cowen

Piper Jaffray's medtech research team holds a conference call

Luminex Corporation Fourth Quarter and Full Year 2011 Earnings Release Scheduled for February 6, 2012

Luminex Corporation Fourth Quarter and Full Year 2011 Earnings Release Scheduled for February 6, 2012

Luminex downgraded to Market Perform from Outperform at Leerink

Luminex Corporation to Present at JP Morgan Healthcare Conference

JP Morgan's life science tools and diagnostics analyst holds a conference call

Luminex downgraded to Underweight from Neutral at JP Morgan

Checking Illumina's Growth

Is Illumina's Stock Expensive or Cheap by the Numbers?

Leerink's life science tools and diagnostics analyst to hold a conference call

Why Luminex May Be About to Take Off

Leerink's life science tools and diagnostics analyst to hold a conference call

Meridian Biosciences ? Stealth Income Play (VIVO, ALR, CPHD, BDX, GPRO, LMNX, ABT)

Luminex Corporation Vice President of Biodefense to Speak at DTRA'S 2011 CBD S&T Conference

See More Articles...